AI-generated summary
The authors describe a single patient with COVID-19 who had two oral opportunistic infections, pseudomembranous candidiasis and recurrent herpes labialis, treated with a combination of antimicrobial photodynamic therapy and photobiomodulation. They report that all lesions resolved within 7 days without systemic drugs. Because this is a single case report, the authors say the approach only seems promising and needs further study.
- Who or what was studied
- One patient with COVID-19 who had oral pseudomembranous candidiasis and recurrent herpes labialis
- Limits stated in the abstract
- The report describes a single case, so no general conclusions can be drawn about effectiveness.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photodynamic therapy, Photobiomodulation, Phototherapy, Case report. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.